CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- 4 Open-market buy Chief Executive Officer bought 6,600 shares at $2.92 ($19,272)
- 4 Open-market buy Chief Executive Officer bought 3,250 shares at $2.99 ($9,718)
- 4 Open-market buy Chief Executive Officer bought 7,000 shares at an average $2.81 ($19,700)
- 4 Open-market buy Director bought 4,386 shares at $2.28 ($10,000)
- 4 Open-market buy Director bought 22,000 shares at $2.28 ($50,160)
- 4 Open-market buy President bought 20,000 shares at $2.28 ($45,600)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 4,106 shares (grant or award)
- 4 Grant or award Director acquired 2,472 shares (grant or award)
- 4 Grant or award Director acquired 4,316 shares (grant or award)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 5,363 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- 424B5 Offering Prospectus
Page 55 of 74 · 1,465 filings